Roche Looks Steady In Headwinds But Under Pressure To Deliver M&A
The Swiss company will see a slight decline in revenues this year as its COVID-19 sales drop off and investors are calling for a return to M&A to help spur growth.
The Swiss company will see a slight decline in revenues this year as its COVID-19 sales drop off and investors are calling for a return to M&A to help spur growth.